Latest filing published 27 Jun 2023 for Insight Molecular Diagnostics Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 15 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -32.4%Entry US$4.08 · Close at T+365 US$2.76
- -58.3%Entry US$6.00 · Close at T+365 US$2.50
- -80.1%Entry US$18.40 · Close at T+365 US$3.66
- +94.4%Entry US$0.15 · Close at T+365 US$0.28
- +109.1%Entry US$0.18 · Close at T+365 US$0.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alfred D. Kingsley: trading record in brief
Alfred D. Kingsley, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Lineage Cell Therapeutics, Inc., Insight Molecular Diagnostics Inc. and Asterias Biotherapeutics, Inc. Over a trading history stretching from 12 April 2006 to 23 June 2023, the count stands at 76 filings.
The open-market side counts 18 purchases for €123k alongside 12 sales for €3.8M. The totals exclude 3 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants and 7 option exercises. Since January 2023: 1 purchase and no sales on the market.
Half of the purchases are above €5,359 and half below. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 15 purchases with a full 90-day history, the hit rate stands at 7% and the median 90-day move at -12.5%. This is a record of the past, not a forecast.
The newest entry dates from 27 June 2023: a share grant, in Insight Molecular Diagnostics Inc. The last purchase on record was published on 15 June 2023, which is 1,243 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alfred D. Kingsley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares0Common Stock, no par valueSEC:0001493152-23-022667:0
- 30,000 shares@ US$0.214947.0% of flowCommon Stock, no par valueSEC:0001493152-23-021531:0Canonical exit: 12 Sept 2023 (T+90)
- 25,000 shares@ US$0.28553.0% of flowCommon Stock, no par valueSEC:0001493152-22-036605:0Canonical exit: 22 Mar 2023 (T+90)
- 5,000 shares@ US$0.972.9% of flowCommon Stock, no par valueSEC:0001493152-22-023383:1Canonical exit: 13 Nov 2022 (T+90)
- 10,000 shares0Common Stock, no par valueSEC:0001493152-22-023383:0
- 10,000 shares0Common Stock, no par valueSEC:0001493152-22-019820:0
- 61,800 shares@ US$2.20100.0% of flowCommon Shares, no par valueSEC:0001493152-21-015072:0
- 1,237 shares@ US$1.340.8% of flowCommon Stock, no par valueSEC:0001493152-20-024410:0
- 900 shares@ US$2.551.2% of flowCommon Stock, no par valueSEC:0001493152-20-024410:1
- 65,271 shares@ US$1.3444.1% of flowCommon Stock, no par valueSEC:0001493152-20-024410:2
- 47,976 shares@ US$1.3432.4% of flowCommon Stock, no par valueSEC:0001493152-20-024283:0
- 5,148 shares@ US$2.546.6% of flowCommon Stock, no par valueSEC:0001493152-20-024283:2
- 10,516 shares@ US$1.347.1% of flowCommon Stock, no par valueSEC:0001493152-20-024283:3
- 30,000 sharesCommon Stock, no par valueSEC:0001493152-20-024283:1
- 7,652 sharesCommon Stock, no par valueSEC:0001493152-20-024283:4
- 5,909 sharesCommon StockSEC:0001493152-20-023586:0
- 6,390 sharesCommon Shares, no par valueSEC:0001209191-19-023894:0
- 300,000 shares@ US$2.8139.2% of flowCommon Shares, no par valueSEC:0001209191-17-049764:0
- 150,000 shares@ US$2.8019.4% of flowCommon Shares, no par valueSEC:0001209191-17-047197:0
- 238,469 sharesCommon Shares, no par valueSEC:0001209191-17-002818:0
- 4,000 shares@ US$2.93100.0% of flowCommon StockSEC:0001140361-16-069461:0Canonical exit: 7 Sept 2016 (T+90)
- 300,000 shares@ US$2.3585.0% of flowCommon Shares, no par valueSEC:0001209191-16-093158:0
- 100,000 shares@ US$3.83Common Shares, no par valueSEC:0001209191-15-079468:0
- 50,000 shares@ US$2.30Common Shares, no par valueSEC:0001209191-14-044869:0
- 300,000 shares@ US$2.45Common Shares, no par valueSEC:0001209191-14-034737:0
25 of 74 declarations
